Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mushboost: Evaluating the Effect of Agaricus Bisporus Powder Intake on the Vaccination Response to an Influenza Vaccine

NCT06041867 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06041867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06041867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mushboost: Evaluating the Effect of Agaricus Bisporus Powder Intake on the Vaccination Response to an Influenza Vaccine
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2023
Completion date
May 30, 2024
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune response